Stichting Radboud universitair medisch centrum

Nijmegen 6525 GA

5 studies enrolling now · 9 studies all time

What they study most

Advanced Gastrointestinal Stromal Tumors, Atherosclerotic Cardiovascular Disease, Breast Neoplasms, Cholangiocarcinoma, Colorectal Neoplasms, DM1, Dry Age-related Macular Degeneration, Dystrophy Myotonic, Esophageal Neoplasms, FSH Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy

Studies at this site

• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — Recruiting now
• A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD — Recruiting now
• (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors — Recruiting now
• A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors — Recruiting now
• Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study — Recruiting now
• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 — Stopped early
• Global Study of Del-desiran for the Treatment of DM1 — Running, not enrolling
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling